Evidence map›Paper›PMID 29352092›Full record

Observational studyJournal of the American Heart Association2018

Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study.

Usman Khalid, Alexander Egeberg, Ole Ahlehoff, Deirdre Lane, Gunnar H Gislason, Gregory Y H Lip, Peter R Hansen

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT04056039. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04056039 phase2completed

Efficacy of Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity as a Biomarker of Myocardial Damage in Patients With Rheumatoid Arthritis With Severe Activity.

Ran2018Enrolled60Registered outcomes3Posted comparisons0ConditionsArthritis, Rheumatoid, Cardiovascular DiseasesArmsAtorvastatin, Colchicine
Open the trial in the graph
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Heart failure in autoimmune rheumatic diseases.Rheumatology international · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Usman KhalidDepartment of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark ukha.usman@gmail.com.
Alexander EgebergDepartment of Dermatology and Allergy, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark.
Ole AhlehoffDepartment of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark.
Deirdre LaneInsititute of Cardiovascular Sciences, University of Birmingham, United Kingdom.
Gunnar H GislasonDepartment of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark.
Gregory Y H LipInsititute of Cardiovascular Sciences, University of Birmingham, United Kingdom.
Peter R HansenDepartment of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark.
Gentofte Hospital · DKUniversity of Birmingham · GBCopenhagen University Hospital · DKUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRheumatoid arthritis (RA) is a chronic inflammatory disease associated with a wide range of comorbidities, including cardiovascular disease, but its association with heart failure (HF) is not fully clear. We investigated the risk of incident HF in a nationwide cohort of patients with RA. METHODS AND

resultsThe study comprised the entire Danish population aged ≥18 years followed from January 1, 2008 until first hospitalization for HF, emigration, December 31, 2012, or death. Information on comorbidity, medication, and socioeconomic status was identified by individual-level linkage of administrative registers. Patients with a rheumatologist diagnosis of RA between 1978 and 2008 were included. The primary study outcome was incident HF defined as first hospital admission for HF. Incidence rates of HF per 1000 person-years were calculated and incidence rate ratios adjusted for age, sex, calendar year, comorbidity, medications, socioeconomic status, smoking, and alcohol consumption were estimated. A total of 4 305 225 subjects with no history of HF were eligible for analysis at the study start. Of these subjects, 24 343 developed RA and 50 623 were hospitalized for HF. Overall incidence rates of incident HF were 2.43 and 6.64 for the reference population (n=49 879) and patients with RA (n=744), respectively. Correspondingly, the fully adjusted incidence rate ratio for incident HF was increased in patients with RA with incidence rate ratio 1.30 (95% confidence interval, 1.17-1.45).

conclusionsIn this cohort study, RA was associated with an increased hospitalization for HF. These findings add significantly to the existing evidence of RA as a clinically relevant risk factor for HF.

Indexed as

AdultAgedArthritis, RheumatoidDenmarkFemaleHeart FailureHospitalizationHumansIncidenceMaleMiddle AgedPrognosisRegistriesRisk AssessmentRisk FactorsTime Factorscardiovascular diseaseheart failureinflammationrheumatoid arthritis

Identifiers

PMID29352092
PMCPMC5850154
OpenAlexW2786215588

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.